Connor, Clark & Lunn Investment Management (CC&L)’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,362
| Closed | -$243K | – | 1422 |
|
|
2023
Q1 | $243K | Sell |
2,362
-5,975
| -72% | -$614K | ﹤0.01% | 1055 |
|
|
2022
Q4 | $1.22M | Sell |
8,337
-2,010
| -19% | -$294K | 0.01% | 662 |
|
|
2022
Q3 | $1.75M | Buy |
+10,347
| New | +$1.75M | 0.01% | 524 |
|
|
2021
Q1 | – | Sell |
-2,425
| Closed | -$1.61M | – | 1049 |
|
|
2020
Q4 | $1.61M | Sell |
2,425
-3,216
| -57% | -$2.14M | 0.01% | 558 |
|
|
2020
Q3 | $2.63M | Sell |
5,641
-784
| -12% | -$365K | 0.02% | 426 |
|
|
2020
Q2 | $3.76M | Buy |
+6,425
| New | +$3.76M | 0.03% | 349 |
|